Ampersand to Acquire Vibalogics

Vibalogics GmbH, a contract development and manufacturing organization (CDMO) focused on complex live biological products, is being acquired by Ampersand Capital Partners, a private equity firm specializing in growth equity investments in the healthcare sector. Ampersand’s growth investment will be used to expand Vibalogics’ capabilities to meet growing industry demand for the development and manufacturing of complex viral products.
 
Vibalogics offers process development, manufacturing and fill & finish of products for biopharmaceutical companies involved in the development of oncolytic viral therapies, gene therapies, and vaccines. With a specific focus on viruses, live bacteria, and aseptic processing, the company’s 50 employees work in full compliance with international GMP standards in a BSL-2 classified state of the art, 27,000 sq. ft. (2,500 m2) facility in Cuxhaven, Germany.
 
"With the benefit of Ampersand as our partner, Vibalogics will now strengthen and expand its position in the U.S. and European markets while further investing in additional process development and GMP manufacturing capabilities," said Stefan Beyer, chief executive officer, Vibalogics. "The partnership solidifies Vibalogics’ existing presence in the biologics manufacturing space and will allow the company to continue to exceed our customers’ expectations by facilitating the development of innovative therapeutic approaches that significantly improve the treatment of patients suffering from cancer and genetic disorders."
 
David Anderson, general partner, Ampersand, "Vibalogics is a leading company in its field. Given the exciting developments within the complex virus market this is an excellent time for an investor with deep experience in the viral vector contract manufacturing sector to partner with the company."

Register as Visitor to CPhI China 2019 NOW!

-----------------------------------------------------------------------
Editor's Note:

If you have any suggestion to the content, 

please email: Julia.Zhang@ubmsinoexpo.com.